Page last updated: 2024-11-05

xylazine and Heart Disease, Ischemic

xylazine has been researched along with Heart Disease, Ischemic in 2 studies

Xylazine: An adrenergic alpha-2 agonist used as a sedative, analgesic and centrally acting muscle relaxant in VETERINARY MEDICINE.
xylazine : A methyl benzene that is 1,3-dimethylbenzene which is substituted by a 5,6-dihydro-4H-1,3-thiazin-2-ylnitrilo group at position 2. It is an alpha2 adrenergic receptor agonist and frequently used in veterinary medicine as an emetic and sedative with analgesic and muscle relaxant properties.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Walsh, RS1
Tsuchida, A1
Daly, JJ1
Thornton, JD1
Cohen, MV1
Downey, JM1
Morita, Y1
Murakami, T1
Iwase, T1
Nagai, K1
Nawada, R1
Kouchi, I1
Akao, M1
Sasayama, S1

Other Studies

2 other studies available for xylazine and Heart Disease, Ischemic

ArticleYear
Ketamine-xylazine anaesthesia permits a KATP channel antagonist to attenuate preconditioning in rabbit myocardium.
    Cardiovascular research, 1994, Volume: 28, Issue:9

    Topics: Animals; Glyburide; Guanidines; Ketamine; Myocardial Infarction; Myocardial Ischemia; Myocardium; Pi

1994
K(ATP) channels contribute to the cardioprotection of preconditioning independent of anaesthetics in rabbit hearts.
    Journal of molecular and cellular cardiology, 1997, Volume: 29, Issue:4

    Topics: Adenosine Triphosphate; Adenylyl Cyclases; Anesthetics; Animals; Cardiotonic Agents; Female; Hemodyn

1997